The GCK gene, also known as glucokinase, is listed in various genetic databases and resources related to genetic testing and health conditions. It is a congenital gene that plays a crucial role in glucose metabolism and the regulation of blood sugar levels.
Changes in the GCK gene have been associated with different conditions, including neonatal hyperinsulinism and maturity-onset diabetes of the young (MODY). Both conditions involve elevated levels of glucose in the body and can have long-term effects on health.
Research and scientific articles provide additional information on the GCK gene, including testing methods, variants, and their implications for different diseases and conditions. Catalogs and databases, such as OMIM and PubMed, list references and resources related to GCK and its associated conditions.
Genetic testing for GCK gene variants can be useful in diagnosing and managing these conditions, particularly in young individuals. The release of information and resources from scientific studies and registries provides valuable insights into the genetic changes and their effects on health.
Health Conditions Related to Genetic Changes
Gene changes can have a significant impact on a person’s health. There are numerous health conditions that are related to genetic changes in various genes. Understanding these conditions is crucial for early diagnosis, treatment, and management of affected individuals.
When it comes to genetic changes, the GCK gene plays a vital role in several health conditions. Below are some articles and information related to health conditions associated with changes in the GCK gene:
Preventable medical errors kill about 22,000 patients a year, according to research from the Yale School of Medicine. That’s much less than a previously reported number of 250,000 deaths a year where medical error is to blame.
-
GCK-associated Hyperinsulinism: This condition is characterized by elevated insulin levels in the body due to changes in the GCK gene. It is a permanent form of hyperinsulinism that usually manifests in infancy or early childhood.
-
GCK-related Maturity-Onset Diabetes of the Young (MODY): Changes in the GCK gene also lead to Maturity-Onset Diabetes of the Young. This form of diabetes typically develops before the age of 25 and is often mistaken for type 1 or type 2 diabetes.
-
GCK Gene Variant and Gestational Diabetes: Variants in the GCK gene have been linked to gestational diabetes, which occurs during pregnancy. Women with a GCK gene variant may have elevated blood glucose levels during pregnancy, requiring monitoring and medical intervention.
-
Congenital Hyperinsulinism Registry: The Congenital Hyperinsulinism Registry provides comprehensive information on genetic changes associated with congenital hyperinsulinism, including those involving the GCK gene. The registry offers resources, testing, and references for affected individuals and their families.
-
OMIM and PubMed: OMIM (Online Mendelian Inheritance in Man) and PubMed are valuable scientific resources that provide information on genetic changes and associated health conditions. They offer a vast catalog of articles and references for further research.
It is important to note that GCK gene changes are not the only genetic changes associated with health conditions. There are numerous other genes with changes that can lead to various diseases and conditions. Genetic testing and further research are essential for identifying these changes and understanding their impact on health.
Maturity-onset diabetes of the young
Maturity-onset diabetes of the young (MODY) is a type of diabetes that is characterized by a young age of onset, typically before the age of 25, and a strong genetic component. MODY is caused by mutations in several different genes, one of which is the GCK gene.
The GCK gene provides instructions for making the enzyme glucokinase, which plays a key role in glucose regulation. Mutations in the GCK gene can result in a reduced ability to regulate blood glucose levels, leading to hyperinsulinism and the development of diabetes. Unlike other forms of diabetes, individuals with MODY do not typically have the characteristic symptoms of insulin resistance.
Testing for mutations in the GCK gene, as well as other genes listed in the MODY catalog, can be done through genetic testing. Genetic testing can help diagnose MODY and distinguish it from other forms of diabetes. It can also provide valuable information for genetic counseling and family planning.
For additional information on MODY and related genetic conditions, the Online Mendelian Inheritance in Man (OMIM) database provides a comprehensive catalog of genes and associated diseases. PubMed is a scientific database that contains articles and references on MODY and related topics.
The release of the Human Gene Mutation Database (HGMD) and the Human Genome Variation Society (HGVS) have also provided valuable resources for the study of genetic diseases, including MODY. These databases contain information on genetic variants and their associated diseases.
In addition to genetic testing, other health tests, such as glucose tolerance tests, can be used to diagnose MODY. However, it is important to note that not all individuals with MODY will have elevated glucose levels, making diagnosis more challenging.
MODY is often mistaken for type 1 or type 2 diabetes, as the symptoms and clinical presentation can be similar. However, the age of onset and permanent changes in glucose regulation are key distinguishing factors for MODY.
The MODY Genetic Testing Registry is a resource that provides information on available testing options and laboratories that offer testing for MODY.
In conclusion, MODY is a genetic form of diabetes with a young age of onset. Mutations in the GCK gene and other genes can result in permanent changes in glucose regulation. Genetic testing and other health tests can help diagnose MODY and distinguish it from other types of diabetes. Several resources, such as OMIM, PubMed, HGMD, and HGVS, provide valuable information on MODY and related genetic conditions.
Congenital hyperinsulinism
Congenital hyperinsulinism is a genetic disorder characterized by an excessive production of insulin by the pancreas, resulting in low blood sugar levels. It can occur in neonatal, infancy, and childhood, or as a maturity-onset condition in young adults.
The GCK gene is one of the genes associated with congenital hyperinsulinism. Genetic testing can identify changes or variants in this gene that may cause the condition. Other genes, such as ABCC8 and KCNJ11, are also commonly involved.
Glucose is a critical molecule for the body as it provides energy. In patients with congenital hyperinsulinism, the excessive release of insulin leads to abnormally low levels of glucose in the blood. This can result in various symptoms, including seizures, developmental delays, and other related conditions.
Diagnosis of congenital hyperinsulinism involves various tests, such as glucose tolerance tests and genetic testing. Genetic testing helps identify the specific genetic changes causing the condition. The GCK gene variant associated with congenital hyperinsulinism can be cataloged and listed in genetic databases, such as OMIM and PubMed.
The Genetic Testing Registry provides additional information on genetic testing and related resources. It catalogs genetic tests for various diseases, including congenital hyperinsulinism and other forms of diabetes.
In conclusion, congenital hyperinsulinism is a genetic disorder characterized by the excessive release of insulin and low blood sugar levels. The GCK gene, along with other genes, plays a significant role in the development of this condition. Genetic testing and resources such as scientific articles, OMIM, PubMed, and the Genetic Testing Registry provide valuable information to understand and diagnose this condition.
Gestational diabetes
Gestational diabetes is a form of diabetes that occurs during pregnancy. It is characterized by elevated levels of glucose in the body and can lead to various health complications for both the mother and the baby.
Like other types of diabetes, gestational diabetes is influenced by genetic factors. Research has identified a variant in the GCK gene, which is associated with an increased risk of developing gestational diabetes.
Genetic changes in the GCK gene can result in elevated glucose levels in the body during pregnancy. This can cause complications such as increased birth weight, neonatal hypoglycemia, and an increased risk of developing type 2 diabetes later in life.
The GCK gene variant associated with gestational diabetes has been listed in various genetic databases, including OMIM and PubMed. These databases provide additional information on the gene variant, its relationship to gestational diabetes, and references to scientific articles that provide more insight into its role in this condition.
In addition to genetic factors, gestational diabetes can also be influenced by other factors such as body weight, age, and family history of diabetes. Testing for gestational diabetes usually involves glucose tolerance tests and monitoring blood sugar levels during pregnancy.
Managing gestational diabetes involves a combination of lifestyle changes, such as a healthy diet and regular exercise, and medication if necessary. It is important for women with gestational diabetes to closely monitor their blood sugar levels and work closely with healthcare providers to maintain optimal health for themselves and their baby.
A registry of individuals with gestational diabetes and related genetic variants provides valuable resources and information for healthcare professionals and researchers studying this condition. The registry helps to track and identify patterns in the occurrence of gestational diabetes and its associated genetic factors.
In conclusion, gestational diabetes is a form of diabetes that occurs during pregnancy and is influenced by genetic factors. The GCK gene variant is one of the genes associated with an increased risk of developing gestational diabetes. Additional research and resources are available to healthcare professionals and researchers to better understand and manage this condition.
Permanent neonatal diabetes mellitus
Permanent neonatal diabetes mellitus (PNDM) is a rare genetic condition characterized by elevated blood glucose levels from birth. It is caused by mutations in the GCK gene, also known as the glucokinase gene. GCK is one of the genes related to maturity-onset diabetes of the young (MODY) and neonatal diabetes.
PNDM is different from other forms of neonatal diabetes, such as those caused by mutations in the KCNJ11 and ABCC8 genes, which are related to congenital hyperinsulinism. PNDM is a form of diabetes that occurs in the neonatal period and persists throughout life.
Testing for mutations in the GCK gene can be done in young children with symptoms of diabetes or those with a family history of the condition. Genetic testing can be done to identify specific changes in the GCK gene that cause PNDM.
The Online Mendelian Inheritance in Man (OMIM) database provides additional information on the GCK gene and its variants. Scientific articles and references related to PNDM can be found in PubMed.
Health databases and registries, such as the Genetic Testing Registry, list genetic testing options for PNDM and related conditions. These resources can provide information on available tests, the names of labs that perform the tests, and any additional resources or support for individuals with PNDM and their families.
In conclusion, permanent neonatal diabetes mellitus is a genetic condition caused by mutations in the GCK gene. It is characterized by elevated blood glucose levels from birth and persists throughout life. Genetic testing and resources are available to diagnose and provide support for individuals with this condition.
Other Names for This Gene
- Hyperinsulinism, familial, 3 (permanent neonatal diabetes mellitus)
- Hyperinsulinism-hyperammonemia syndrome
- HHF3
- GCKD, MODY2
- Maturity-onset diabetes of the young, type 2
- Glucokinase-related hyperinsulinemic hypoglycemia
- GCK-modified hyperinsulinism
- Hyperinsulinism due to glucokinase deficiency
- GCKD
- Glucokinase deficiency
These are some of the other names for the GCK gene. The GCK gene is associated with genetic diseases related to diabetes, including congenital hyperinsulinism (permanent neonatal diabetes mellitus) and maturity-onset diabetes of the young, type 2. There are several databases and resources available for genetic testing and information about changes in this gene, including OMIM, PubMed, and the GCK Gene Catalog. Additional references and scientific articles can also provide information on related conditions and genetic tests.
Additional Information Resources
The GCK gene is associated with various diseases, including neonatal diabetes, maturity-onset diabetes of the young, and congenital hyperinsulinism. If you are looking for more information on these conditions and related genetic changes, the following resources may be helpful:
- PubMed: PubMed provides a vast collection of scientific articles on genetic changes, diseases, and other related topics. You can search for articles on specific conditions or genes associated with GCK.
- OMIM: OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of human genes and genetic conditions. It provides detailed information on different genetic changes and their associated diseases.
- Genetic Testing Registry: The Genetic Testing Registry lists genetic tests available for various conditions, including those related to the GCK gene. You can find information about specific testing methods and laboratories that offer them.
- Health-related Websites: Several health-related websites provide information on neonatal diabetes, maturity-onset diabetes of the young, and other related conditions. They often include details on symptoms, treatment options, and support resources.
These resources provide valuable references and additional information on the GCK gene, genetic changes, and conditions associated with it. They can help you stay updated on the latest research and findings in the field of glucose metabolism and genetic testing.
Tests Listed in the Genetic Testing Registry
The Genetic Testing Registry (GTR) provides a catalog of genetic tests and related information. These tests are listed based on their association with the GCK gene and its variants.
The GCK gene, also known as glucokinase, is responsible for producing an enzyme that plays a crucial role in glucose metabolism. Variants in this gene can lead to changes in the glucose levels in the body, which can result in various health conditions.
Some of the conditions related to GCK gene variants include:
- Neonatal diabetes
- Maturity-onset diabetes of the young
- Gestational diabetes
- Hyperinsulinism
- Congenital hyperinsulinism
The GTR provides references to scientific articles, OMIM entries, and other resources that contain further information about these conditions and the genetic tests associated with them.
Genetic testing for GCK gene variants can help identify individuals who have an elevated risk for developing these conditions. It can also aid in the diagnosis of individuals who already exhibit symptoms related to the variants.
One of the resources listed in the GTR is PubMed, which is a database of scientific articles. This database contains additional information about the GCK gene, its variants, and the diseases associated with them.
The release of tests for genetic changes in the GCK gene has provided valuable resources for the diagnosis and management of neonatal and other diabetes-related conditions. These tests have helped healthcare professionals make informed decisions about treatment options and genetic counseling.
| Test Name | Condition |
|---|---|
| Test 1 | Condition 1 |
| Test 2 | Condition 2 |
| Test 3 | Condition 3 |
The table above provides examples of the tests and conditions associated with the GCK gene. However, there are many other tests and conditions that can be found in the Genetic Testing Registry.
Overall, the Genetic Testing Registry serves as a valuable resource for healthcare professionals and researchers seeking information about genetic testing related to the GCK gene and its variants.
Scientific Articles on PubMed
PubMed provides a rich collection of scientific articles on various topics, including the GCK gene. This gene is associated with glucose metabolism and is involved in the regulation of blood glucose levels in the body.
Genetic changes in the GCK gene can lead to several diseases and conditions, such as hyperinsulinism, gestational diabetes mellitus, maturity-onset diabetes of the young, and neonatal hyperinsulinism.
Testing for genetic variants in the GCK gene can provide important information about the risk of developing these conditions and can guide medical management and treatment.
PubMed lists numerous articles that focus on the GCK gene and its relationship to various health conditions. These articles contain references to additional resources and databases, such as OMIM (Online Mendelian Inheritance in Man), that provide permanent records of genetic changes and associated diseases.
Some articles provide detailed information on the testing methods and protocols used to identify genetic changes in the GCK gene. Others discuss the clinical implications and management strategies for individuals with GCK gene variants.
Research on the GCK gene is particularly relevant for young individuals with neonatal or congenital forms of hyperinsulinism, as well as those with a family history or personal risk factors for gestational diabetes mellitus or maturity-onset diabetes of the young.
PubMed offers a catalog of scientific articles on the GCK gene, making it a valuable resource for researchers, healthcare professionals, and individuals interested in genetic testing and personalized medicine.
Catalog of Genes and Diseases from OMIM
The Catalog of Genes and Diseases from OMIM (Online Mendelian Inheritance in Man) is a comprehensive resource that provides information on genetic changes, diseases, and conditions. This catalog lists genes associated with various conditions, including glucose changes, congenital diabetes, maturity-onset diabetes mellitus, and neonatal hyperinsulinism, among others.
For each gene listed, the catalog provides the gene’s name, related diseases, and genetic changes associated with the conditions. Additionally, the catalog includes references to scientific articles and other resources that have further information on the gene or disease.
In addition to the catalog, OMIM also provides a registry of genetic tests for various diseases and conditions. This registry offers information on available tests, testing laboratories, and their validity.
OMIM is a valuable resource for health professionals, researchers, and individuals interested in genetic conditions. It is frequently updated to include the latest information, and the release of new and related genes is promptly added to the catalog.
For additional information on any gene or disease listed in the catalog, users can refer to the provided references, which often include PubMed articles and links to related databases.
| Gene | Associated Diseases | Genetic Changes |
|---|---|---|
| GCK | Gestational diabetes mellitus, permanent neonatal diabetes mellitus | Variant GCK gene |
| ABCC8 | Congenital hyperinsulinism | Genetic changes on the ABCC8 gene |
| NEUROD1 | Maturity-onset diabetes of the young | Genetic changes on the NEUROD1 gene |
Please note that this is just a small sample from the Catalog of Genes and Diseases provided by OMIM. The catalog contains information on many more genes and diseases, and it constantly expands as new discoveries are made.
Gene and Variant Databases
Gene and variant databases provide valuable resources for genetic testing and research related to health conditions and diseases. These databases catalog information about changes in genes and variants associated with various genetic conditions.
The Online Mendelian Inheritance in Man (OMIM) database is a comprehensive resource that provides information on genetic conditions, genes, and variants. OMIM lists genetic changes associated with a wide range of diseases and provides references to published articles and other resources for further reading.
The Genetic Testing Registry (GTR) is another database that offers information on genetic tests and their associated genes. GTR provides a catalog of genetic tests available for various conditions, including gestational diabetes mellitus, neonatal hyperinsulinism, and maturity-onset diabetes of the young. It also lists genes and variants associated with these conditions.
In addition to these databases, there are also variant databases that focus on specific genetic conditions. For example, the ABCC8 and KCNJ11 genes are associated with congenital hyperinsulinism, and there are specific databases available for these genes.
These databases play a crucial role in providing a centralized source of information on genetic conditions and their associated genes. They help researchers and healthcare professionals access the latest information on genetic changes, allowing them to better understand and diagnose a wide range of conditions.
References
- OMIM: GCK Gene – Entry #232200
- PubMed: Publications on GCK gene
- Catalog of Genes and Diseases: GCK gene – Gene ID: 2645
- Registry of Genomic Variants: GCK gene – Genetic variation
- Genetic Testing Registry: GCK gene – Genetic tests
Additional information on GCK gene can be found in articles published in scientific journals and health resources. The elevated glucose levels, changes in glucose metabolism, and maturity-onset diabetes of the young (MODY) condition related to GCK gene can be studied in these resources.
| Type | Resources |
|---|---|
| Scientific Articles | PubMed |
| Health Resources | OMIM |
OMIM and PubMed provide references to related articles and databases that list the genetic changes and conditions associated with GCK gene. These resources offer additional information on genetic testing, gene names, and other genes related to GCK. The OMIM entry for GCK gene includes a list of diseases and conditions, such as neonatal hyperinsulinism and congenital hyperinsulinism, which are associated with this gene.